Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v7-EN
Language French English
Date Updated 2022-12-13 2020-06-15
Drug Identification Number 02416255 02416255
Brand name APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE
Common or Proper name ABACAVIR-LAMIVUDINE-ZIDOVUDINE ABACAVIR-LAMIVUDINE-ZIDOVUDINE
Company Name APOTEX INC APOTEX INC
Ingredients ZIDOVUDINE ABACAVIR LAMIVUDINE ZIDOVUDINE ABACAVIR LAMIVUDINE
Strength(s) 300MG 300MG 150MG 300MG 300MG 150MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 60BTL 60BTL
ATC code J05AR J05AR
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-12-03 2018-12-03
Estimated end date Unknown Unknown
Actual end date 2022-12-02
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments